BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 24456695)

  • 1. The COPD assessment test (CAT) assists prediction of COPD exacerbations in high-risk patients.
    Lee SD; Huang MS; Kang J; Lin CH; Park MJ; Oh YM; Kwon N; Jones PW; Sajkov D;
    Respir Med; 2014 Apr; 108(4):600-8. PubMed ID: 24456695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in COPD.
    Miravitlles M; García-Sidro P; Fernández-Nistal A; Buendía MJ; Espinosa de Los Monteros MJ; Esquinas C; Molina J
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2571-9. PubMed ID: 26664105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the effectiveness of the COPD Assessment Test (CAT) to evaluate COPD severity and exacerbation rates.
    Varol Y; Ozacar R; Balci G; Usta L; Taymaz Z
    COPD; 2014 Apr; 11(2):221-5. PubMed ID: 24111793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of COPD Assessment Test and Clinical COPD Questionnaire to predict the risk of exacerbation.
    Jo YS; Yoon HI; Kim DK; Yoo CG; Lee CH
    Int J Chron Obstruct Pulmon Dis; 2018; 13():101-107. PubMed ID: 29317814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COPD exacerbations associated with the modified Medical Research Council scale and COPD assessment test among Humana Medicare members.
    Pasquale MK; Xu Y; Baker CL; Zou KH; Teeter JG; Renda AM; Davis CC; Lee TC; Bobula J
    Int J Chron Obstruct Pulmon Dis; 2016; 11():111-21. PubMed ID: 26834468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CAT (COPD Assessment Test) questionnaire as a predictor of the evolution of severe COPD exacerbations.
    García-Sidro P; Naval E; Martinez Rivera C; Bonnin-Vilaplana M; Garcia-Rivero JL; Herrejón A; Malo de Molina R; Marcos PJ; Mayoralas-Alises S; Ros JA; Valle M; Esquinas C; Barrecheguren M; Miravitlles M
    Respir Med; 2015 Dec; 109(12):1546-52. PubMed ID: 26542727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COPD assessment test: a simple tool to evaluate disease severity and response to treatment.
    Papaioannou M; Pitsiou G; Manika K; Kontou P; Zarogoulidis P; Sichletidis L; Kioumis IP
    COPD; 2014 Sep; 11(5):489-95. PubMed ID: 24766370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic obstructive pulmonary disease assessment test: usefulness for monitoring recovery and predicting poor course of disease after exacerbations.
    Pulido Herrero E; García Gutiérrez S; Antón Ladislao A; Piñera Salmerón P; Martín Corral MJ; Gorordo Unzueta MI; Lopetegui Eraso P; García Lamberechts EJ; Quintana López JM
    Emergencias; 2019 Feb; 31(1):21-26. PubMed ID: 30656869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of acute deterioration in health status visit among COPD patients by monitoring COPD assessment test score.
    Pothirat C; Chaiwong W; Limsukon A; Deesomchok A; Liwsrisakun C; Bumroongkit C; Theerakittikul T; Phetsuk N
    Int J Chron Obstruct Pulmon Dis; 2015; 10():277-82. PubMed ID: 25678783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of a COPD population categorised using the GOLD framework by health status and exacerbations.
    Jones PW; Nadeau G; Small M; Adamek L
    Respir Med; 2014 Jan; 108(1):129-35. PubMed ID: 24041746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Components of the Chronic Obstructive Pulmonary Disease Assessment Test Associated with the Exacerbation of Severe Chronic Obstructive Pulmonary Disease Patients.
    Kim NY; Han J; Hwang YI; Park YB; Park SJ; Park J; Jung KS; Yoo KH; Lee JH; Lee CY
    Respiration; 2024; 103(6):326-335. PubMed ID: 38471463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [How exactly can we predict the prognosis of COPD].
    Atiş S; Kanik A; Ozgür ES; Eker S; Tümkaya M; Ozge C
    Tuberk Toraks; 2009; 57(3):289-97. PubMed ID: 19787468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Role of the Chronic Obstructive Pulmonary Disease Assessment Test in Prediction of the Response to Treatment for Exacerbations.
    Yoon S; Kim TE; Kim TH; Na JO; Shin KC; Rhee CK; Jung SS; Choe KH; Yoo KH
    J Korean Med Sci; 2020 Jan; 35(2):e10. PubMed ID: 31920016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and spirometric variables are better predictors of COPD exacerbations than routine blood biomarkers.
    Nuñez A; Marras V; Harlander M; Mekov E; Turel M; Petkov R; Lestan D; Yanev N; Negri S; Barrecheguren M; Pirina P; Miravitlles M; Esquinas C
    Respir Med; 2020 Sep; 171():106091. PubMed ID: 32829181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A two-year evaluation of the 'real life' impact of COPD on patients in Germany: The DACCORD observational study.
    Kardos P; Vogelmeier C; Worth H; Buhl R; Lossi NS; Mailänder C; Criée CP
    Respir Med; 2017 Mar; 124():57-64. PubMed ID: 28284322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COPD assessment tests scores are associated with exacerbated chronic obstructive pulmonary disease in Japanese patients.
    Suetomo M; Kawayama T; Kinoshita T; Takenaka S; Matsuoka M; Matsunaga K; Hoshino T
    Respir Investig; 2014 Sep; 52(5):288-95. PubMed ID: 25169844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial.
    Rabe KF; Fabbri LM; Israel E; Kögler H; Riemann K; Schmidt H; Glaab T; Vogelmeier CF
    Lancet Respir Med; 2014 Jan; 2(1):44-53. PubMed ID: 24461901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year change in health status and subsequent outcomes in COPD.
    Wilke S; Jones PW; Müllerova H; Vestbo J; Tal-Singer R; Franssen FM; Agusti A; Bakke P; Calverley PM; Coxson HO; Crim C; Edwards LD; Lomas DA; MacNee W; Rennard SI; Yates JC; Wouters EF; Spruit MA
    Thorax; 2015 May; 70(5):420-5. PubMed ID: 25782757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to evaluate severity of COPD exacerbations.
    Mackay AJ; Donaldson GC; Patel AR; Jones PW; Hurst JR; Wedzicha JA
    Am J Respir Crit Care Med; 2012 Jun; 185(11):1218-24. PubMed ID: 22281834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How should we define and classify exacerbations in chronic obstructive pulmonary disease?
    Trigueros Carrero JA
    Expert Rev Respir Med; 2013 Apr; 7(2 Suppl):33-41. PubMed ID: 23551022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.